↓ Skip to main content

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors

Overview of attention for article published in Frontiers in oncology, December 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
3 X users
patent
1 patent

Citations

dimensions_citation
161 Dimensions

Readers on

mendeley
215 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
Published in
Frontiers in oncology, December 2018
DOI 10.3389/fonc.2018.00608
Pubmed ID
Authors

Francesco Schettini, Irene De Santo, Carmen G. Rea, Pietro De Placido, Luigi Formisano, Mario Giuliano, Grazia Arpino, Michelino De Laurentiis, Fabio Puglisi, Sabino De Placido, Lucia Del Mastro

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 215 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 215 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 28 13%
Student > Ph. D. Student 26 12%
Researcher 21 10%
Student > Master 17 8%
Student > Doctoral Student 10 5%
Other 35 16%
Unknown 78 36%
Readers by discipline Count As %
Medicine and Dentistry 44 20%
Biochemistry, Genetics and Molecular Biology 40 19%
Pharmacology, Toxicology and Pharmaceutical Science 18 8%
Agricultural and Biological Sciences 7 3%
Immunology and Microbiology 5 2%
Other 15 7%
Unknown 86 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2023.
All research outputs
#7,137,938
of 25,641,627 outputs
Outputs from Frontiers in oncology
#2,425
of 22,758 outputs
Outputs of similar age
#135,723
of 446,878 outputs
Outputs of similar age from Frontiers in oncology
#39
of 228 outputs
Altmetric has tracked 25,641,627 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 22,758 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,878 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 228 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.